Oorsprong van het eerstegraads netwerk van Ellery Mangas
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Generic | 16 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ellery Mangas via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
DYAX CORP. | Pharmaceuticals: Major | Chief Administrative Officer | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Chairman | |
OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member | |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
OPTOS PLC | Medical Specialties | Director/Board Member | |
Boston College | College/University | Graduate Degree | |
Williams College | College/University | Undergraduate Degree Undergraduate Degree | |
New York Medical College | College/University | Corporate Officer/Principal | |
OXURION NV | Pharmaceuticals: Major | Director/Board Member | |
Simon-Kucher & Partners GmbH
Simon-Kucher & Partners GmbH Miscellaneous Commercial ServicesCommercial Services Simon-Kucher & Partners GmbH provides strategy, marketing and pricing services. It offers consulting services in the areas of setting and managing prices, strategic development, product and market strategy, marketing leadership, and sales execution. The firm has offices in Amsterdam, Bonn, Boston, Brussels, Cologne, Frankfurt, London, Luxembourg, Barcelona, Madrid, Milan, Moscow, Munich, New York, Paris, San Francisco, Tokyo, Vienna, Warsaw, Beijing, Singapore, Sydney and Zurich. The company was founded by Hermann Simon, Eckhard Kucher and Karl-Heinz Sebastian in 1985 and is headquartered in Bonn, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
IVERIC BIO, INC. | Pharmaceuticals: Generic | Director of Finance/CFO Chief Executive Officer | |
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member | |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Carter BloodCare
Carter BloodCare Miscellaneous Commercial ServicesCommercial Services Carter BloodCare engages in the provision of blood components and transfusion services for North, Central and East Texas. It offers collection, testing, and distribution of blood on a local level. It also provides technical support services and educational programs to employees of area healthcare organizations. The company was founded on January 1, 1998 and is headquartered in Bedford, TX. | Miscellaneous Commercial Services | Director/Board Member | |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Imagen Biotech, Inc.
Imagen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Imagen Biotech, Inc. develops therapeutics for sight-threatening diseases. The firm specializes in personalized chemotherapy, medicine, high content screening, cell biology and contract research. The company was founded by David R. Guyer and Matthew Feinsod in 2011 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Harvard Kennedy School of Government | College/University | Graduate Degree | |
Yale College | College/University | Undergraduate Degree | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Private Equity Investor | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Interius BioTherapeutics, Inc.
Interius BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Founder | |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Invectys, Inc.
Invectys, Inc. Pharmaceuticals: MajorHealth Technology Invectys, Inc. is a biopharmaceutical company that focuses on developing immunotherapy treatments for cancer. The private company is based in Houston, TX. Invectys was founded in 2010 and Praveen Tyle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Biotechnology | Chairman | |
Eyebiotech Ltd.
Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
ViTToria Biotherapeutics, Inc.
ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Biotechnology | Founder | |
New York University School of Medicine | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 41 |
Verenigd Koninkrijk | 6 |
België | 3 |
Duitsland | 2 |
Canada | 2 |
Sectoraal
Health Technology | 39 |
Consumer Services | 8 |
Commercial Services | 4 |
Finance | 3 |
Operationeel
Director/Board Member | 93 |
Corporate Officer/Principal | 34 |
Independent Dir/Board Member | 26 |
Director of Finance/CFO | 14 |
Chief Tech/Sci/R&D Officer | 10 |
Sterkste connecties
Insiders | |
---|---|
Arnold Lewis Oronsky | 35 |
Bruce Peacock | 28 |
David Guyer | 27 |
Anne VanLent | 23 |
Bill Aliski | 12 |
Michael H. Goldstein | 12 |
Theresa Heah | 10 |
Rabia Ozden | 9 |
Andrew Ashe | 7 |
Lawrence E. Bullock | 7 |
William A. Sullivan | 7 |
Brian Krex | 7 |
Andrew Limbek | 6 |
Lanita C. Scott | 1 |
Karen M. Carroll | 1 |
- Beurs
- Insiders
- Ellery Mangas
- Bedrijfsconnecties